TUMOR NECROSIS FACTOR-ALPHA-INDUCED PHOSPHORYLATION AND ACTIVATION OFCYTOSOLIC PHOSPHOLIPASE A(2) ARE ABROGATED BY AN INHIBITOR OF THE P38MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE IN HUMAN NEUTROPHILS
Wh. Waterman et al., TUMOR NECROSIS FACTOR-ALPHA-INDUCED PHOSPHORYLATION AND ACTIVATION OFCYTOSOLIC PHOSPHOLIPASE A(2) ARE ABROGATED BY AN INHIBITOR OF THE P38MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE IN HUMAN NEUTROPHILS, Biochemical journal, 319, 1996, pp. 17-20
The role of the newly identified p38 mitogen-activated protein kinase
(MAP kinase) in terminally differentiated cells, such as human neutrop
hils, is totally unknown. In order to examine the possible role of thi
s MAP kinase in the phosphorylation and activation of cytoplasmic phos
pholipase A(2) (cPLA(2)), we tested the effect of the recently synthes
ized inhibitor of p38 MAP kinase, SE 203580, on the phosphorylation an
d activation of both p38 MAP kinase and cPLA(2). We found that while t
umour necrosis factor-alpha (TNF-alpha)-stimulated tyrosine phosphoryl
ation of p38 MAP kinase is affected only slightly by SE 203580, its st
imulated kinase activity is greatly reduced in human neutrophils in su
spension treated with this inhibitor. Furthermore, the TNF-alpha-stimu
lated phosphorylation and activation of cPLA(2) are completely abolish
ed in cells treated with SE 203580. Based on these data, it is reasona
ble to conclude that an SE 203580-sensitive kinase, or kinases and/or
phosphatases, are involved in the phosphorylation and activation of cP
LA(2) in intact human neutrophils in suspension stimulated by TNF-alph
a. The possible role of the p38 MAP kinase cascade in the phosphorylat
ion and activation of cPLA(2) is discussed.